AGE

, Volume 35, Issue 3, pp 563–572

The role of the T cell in age-related inflammation

  • Richard Macaulay
  • Arne N. Akbar
  • Sian M. Henson
Article

Abstract

Ageing is accompanied by alterations to T-cell immunity and also by a low-grade chronic inflammatory state termed inflammaging. The significance of these phenomena is highlighted by their being predictors of earlier mortality. We have recently published that the proinflammatory cytokine TNFα is a strong inducer of CD4+ T-cell senescence and T-cell differentiation, adding to the growing body of literature implicating proinflammatory molecules in mediating these critical age-related T-cell alterations. Moreover, the inflammatory process is also being increasingly implicated in the pathogenesis of many common and severe age-related diseases, including cancer, cardiovascular diseases and type 2 diabetes. Furthermore, major age-related risk factors for poor health, such as obesity, stress and smoking, are also associated with an upregulation in systemic inflammatory markers. We propose the idea that the ensuing inflammatory response to influenza infection propagates cardiovascular diseases and constitutes a major cause of influenza-related mortality. While inflammation is not a negative phenomenon per se, this age-related dysregulation of inflammatory responses may play crucial roles driving age-related pathologies, T-cell immunosenescence and CMV reactivation, thereby underpinning key features of the ageing process.

Keywords

Immunosenescence Inflammaging Influenza Inflammation TNFα p38 

References

  1. Abu-Taha M, Rius C, Hermenegildo C, Noguera I, Cerda-Nicolas JM, Issekutz AC, Jose PJ, Cortijo J, Morcillo EJ, Sanz MJ (2009) Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J Immunol 183:1393–1402PubMedGoogle Scholar
  2. Akbar AN, Henson SM (2011) Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol 11:289–295PubMedGoogle Scholar
  3. Bagnara GP, Bonsi L, Strippoli P, Bonifazi F, Tonelli R, D’Addato S, Paganelli R, Scala E, Fagiolo U, Monti D, Cossarizza A, Bonafe M, Franceschi C (2000) Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. J Gerontol A Biol Sci Med Sci 55:B61–B66PubMedGoogle Scholar
  4. Bakhru A, Erlinger TP (2005) Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2:e160PubMedPubMedCentralGoogle Scholar
  5. Ballou SP, Lozanski FB, Hodder S, Rzewnicki DL, Mion LC, Sipe JD, Ford AB, Kushner I (1996) Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Aging 25:224–230Google Scholar
  6. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506PubMedGoogle Scholar
  7. Baxter R, Lee J, Fireman B (2010) Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 201:186–189PubMedGoogle Scholar
  8. Beenakker KG, Ling CH, Meskers CG, de Craen AJ, Stijnen T, Westendorp RG, Maier AB (2010) Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 9:431–436PubMedGoogle Scholar
  9. Birkenkamp KU, Coffer PJ (2003) Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans 31:292–297PubMedGoogle Scholar
  10. Bruns H, Meinken C, Schauenberg P, Harter G, Kern P, Modlin RL, Antoni C, Stenger S (2009) Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 119:1167–1177PubMedPubMedCentralGoogle Scholar
  11. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JB, Pedersen BK, Jeune B (2003a) Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 115:278–283PubMedGoogle Scholar
  12. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK (2003b) Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 132:24–31PubMedPubMedCentralGoogle Scholar
  13. Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, Goronzy JJ (2005) Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum 52:2996–3003PubMedGoogle Scholar
  14. Calado RT, Young NS (2009) Telomere diseases. N Engl J Med 361:2353–2365PubMedPubMedCentralGoogle Scholar
  15. Campitelli MA, Rosella LC, Stukel TA, Kwong JC (2010) Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine 29:240–246PubMedGoogle Scholar
  16. Carrel AL, McVean JJ, Clark RR, Peterson SE, Eickhoff JC, Allen DB (2009) School-based exercise improves fitness, body composition, insulin sensitivity, and markers of inflammation in non-obese children. J Pediatr Endocrinol Metab 22:409–415PubMedGoogle Scholar
  17. Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361:393–395PubMedGoogle Scholar
  18. Centres for Disease Control and Prevention. Seasonal influenza (flu). Available at: http:www.cdc.gov/flu/about/qa/disease.htm Accessed 15 April 2010. Ref Type: Internet Communication
  19. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107:3133–3140PubMedGoogle Scholar
  20. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP (2006) The molecular inflammatory process in aging. Antioxid Redox Signal 8:572–581PubMedGoogle Scholar
  21. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756–763PubMedGoogle Scholar
  22. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C (2009) Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 8:18–30PubMedPubMedCentralGoogle Scholar
  23. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS (1997) The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52:M201–M208PubMedGoogle Scholar
  24. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J (2008) Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 216:152–155PubMedGoogle Scholar
  25. Debigare R, Cote CH, Maltais F (2001) Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 164:1712–1717PubMedGoogle Scholar
  26. Derhovanessian E, Maier AB, Beck R, Jahn G, Hahnel K, Slagboom PE, de Craen AJ, Westendorp RG, Pawelec G (2010) Hallmark features of immunosenescence are absent in familial longevity. J Immunol 185:4618–4624PubMedGoogle Scholar
  27. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497PubMedGoogle Scholar
  28. Di Mitri D, Azevedo RI, Henson SM, Libri V, Riddell NE, Macaulay R, Kipling D, Soares MV, Battistini L, Akbar AN (2011) Reversible senescence in human CD4+CD45RA+. J Immunol 187:2093–2100PubMedGoogle Scholar
  29. Dinarello CA (2011) Blocking interleukin-1beta in acute and chronic autoinflammatory diseases. J Intern Med 269:16–28PubMedPubMedCentralGoogle Scholar
  30. Dodeller F, Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H (2005) The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells. Eur J Immunol 35:3631–3642PubMedGoogle Scholar
  31. Dunne PJ, Belaramani L, Fletcher JM, Fernandez DM, Lawrenz M, Soares MV, Rustin MH, Lam EW, Salmon M, Akbar AN (2005) Quiescence and functional reprogramming of Epstein–Barr virus (EBV)-specific CD8+ T cells during persistent infection. Blood 106:558–565PubMedGoogle Scholar
  32. El Ani D, Zimlichman R, Mashiach Y, Shainberg A (2007) Adenosine and TNF-alpha exert similar inotropic effect on heart cultures, suggesting a cardioprotective mechanism against hypoxia. Life Sci 81:803–813PubMedGoogle Scholar
  33. Ershler WB (2007) A gripping reality: oxidative stress, inflammation, and the pathway to frailty. J Appl Physiol 103:3–5PubMedGoogle Scholar
  34. Feldmann M, Maini RN (2003) Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med 9:1245–1250PubMedGoogle Scholar
  35. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, Salmon M, Rustin MH, Akbar AN (2005) Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175:8218–8225PubMedGoogle Scholar
  36. Fontana L (2009) Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp Gerontol 44:41–45PubMedPubMedCentralGoogle Scholar
  37. Forsythe LK, Wallace JM, Livingstone MB (2008) Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21:117–133PubMedGoogle Scholar
  38. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254PubMedGoogle Scholar
  39. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105PubMedGoogle Scholar
  40. Freeman RB Jr (2009) The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant 9:2453–2458PubMedGoogle Scholar
  41. Geist LJ, Hopkins HA, Dai LY, He B, Monick MM, Hunninghake GW (1997) Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-alpha promoter. Am J Respir Cell Mol Biol 16:31–37PubMedGoogle Scholar
  42. Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, Chaudhuri A, Dandona P (2010) An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab 95:E1–E8PubMedPubMedCentralGoogle Scholar
  43. Giunta S (2008) Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflamm Res 57:558–563PubMedGoogle Scholar
  44. Gomez CR, Acuna-Castillo C, Nishimura S, Perez V, Escobar A, Salazar-Onfray F, Sabaj V, Torres C, Walter R, Sierra F (2006) Serum from aged F344 rats conditions the activation of young macrophages. Mech Ageing Dev 127:257–263PubMedGoogle Scholar
  45. Gonzalez O, Tobia C, Ebersole J, Novak M (2011) Caloric restriction and chronic inflammatory diseases. Oral Dis 18:16–31PubMedPubMedCentralGoogle Scholar
  46. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J (2010) Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy. Ann N Y Acad Sci 1193:153–159PubMedGoogle Scholar
  47. Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24:1159–1169PubMedGoogle Scholar
  48. Gorczynski RM, Terzioglu E (2008) Aging and the immune system. Int Urol Nephrol 40:1117–1125PubMedGoogle Scholar
  49. Goronzy JJ, Shao L, Weyand CM (2010) Immune aging and rheumatoid arthritis. Rheum Dis Clin North Am 36:297–310PubMedPubMedCentralGoogle Scholar
  50. Gouin JP, Hantsoo L, Kiecolt-Glaser JK (2008) Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation 15:251–259PubMedPubMedCentralGoogle Scholar
  51. Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104–i108PubMedGoogle Scholar
  52. Gupta S, Bi R, Kim C, Chiplunkar S, Yel L, Gollapudi S (2005) Role of NF-kappaB signaling pathway in increased tumor necrosis factor-alpha-induced apoptosis of lymphocytes in aged humans. Cell Death Differ 12:177–183PubMedGoogle Scholar
  53. Gupta S, Su H, Bi R, Gollapudi S (2006) Differential sensitivity of naive and memory subsets of human CD8+ T cells to TNF-alpha-induced apoptosis. J Clin Immunol 26:193–203PubMedGoogle Scholar
  54. Haynes L, Eaton SM (2005) The effect of age on the cognate function of CD4+ T cells. Immunol Rev 205:220–228PubMedPubMedCentralGoogle Scholar
  55. Haynes L, Eaton SM, Swain SL (2000) The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines. Vaccine 18:1649–1653PubMedGoogle Scholar
  56. Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, Nguyen T, Martin CK, Volaufova J, Most MM, Greenway FL, Smith SR, Deutsch WA, Williamson DA, Ravussin E (2006) Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295:1539–1548PubMedPubMedCentralGoogle Scholar
  57. Ho JE, Hsue PY (2009) Cardiovascular manifestations of HIV infection. Heart 95:1193–1202PubMedGoogle Scholar
  58. Ingram DK, Anson RM, de Cabo R, Mamczarz J, Zhu M, Mattison J, Lane MA, Roth GS (2004) Development of calorie restriction mimetics as a prolongevity strategy. Ann N Y Acad Sci 1019:412–423PubMedGoogle Scholar
  59. Jolly CA (2004) Dietary restriction and immune function. J Nutr 134:1853–1856PubMedGoogle Scholar
  60. Kebschull M, Demmer RT, Papapanou PN (2010) “Gum bug, leave my heart alone!”—epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res 89:879–902PubMedPubMedCentralGoogle Scholar
  61. Kim HJ, Jung KJ, Yu BP, Cho CG, Choi JS, Chung HY (2002) Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech Ageing Dev 123:1589–1595PubMedGoogle Scholar
  62. Kim DH, Kim JY, Yu BP, Chung HY (2008) The activation of NF-kappaB through Akt-induced FOXO1 phosphorylation during aging and its modulation by calorie restriction. Biogerontology 9:33–47PubMedGoogle Scholar
  63. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:316–321PubMedGoogle Scholar
  64. Larbi A, Pawelec G, Wong SC, Goldeck D, Tai JJ, Fulop T (2011) Impact of age on T cell signaling: a general defect or specific alterations? Ageing Res Rev 10:370–378PubMedGoogle Scholar
  65. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P (2002) Association between influenza vaccination and reduced risk of brain infarction. Stroke 33:513–518PubMedGoogle Scholar
  66. Lencel P, Magne D (2011) Inflammaging: the driving force in osteoporosis? Med Hypotheses 76:317–321PubMedGoogle Scholar
  67. Li C, Beavis P, Palfreeman AC, Amjadi P, Kennedy A, Brennan FM (2011a) Activation of p38 mitogen-activated protein kinase is critical step for acquisition of effector function in cytokine-activated T cells, but acts as a negative regulator in T cells activated through the T-cell receptor. Immunology 132:104–110PubMedPubMedCentralGoogle Scholar
  68. Li H, Yan Z, Zhu J, Yang J, He J (2011b) Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats. Neuropharmacology 60:252–258PubMedGoogle Scholar
  69. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725–734Google Scholar
  70. Libby P, Okamoto Y, Rocha VZ, Folco E (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ J 74:213–220PubMedGoogle Scholar
  71. Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C (2005) Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2:8PubMedPubMedCentralGoogle Scholar
  72. Maggio M, Basaria S, Ble A, Lauretani F, Bandinelli S, Ceda GP, Valenti G, Ling SM, Ferrucci L (2006) Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 91:345–347PubMedGoogle Scholar
  73. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109:1594–1602PubMedGoogle Scholar
  74. Merritt C, Enslen H, Diehl N, Conze D, Davis RJ, Rincon M (2000) Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells. Mol Cell Biol 20:936–946PubMedPubMedCentralGoogle Scholar
  75. Messaoudi I, Fischer M, Warner J, Park B, Mattison J, Ingram DK, Totonchy T, Mori M, Nikolich-Zugich J (2008) Optimal window of caloric restriction onset limits its beneficial impact on T-cell senescence in primates. Aging Cell 7:908–919PubMedPubMedCentralGoogle Scholar
  76. Monteiro R, Azevedo I (2010) Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm doi:10.1155/2010/289645
  77. Morales I, Farias G, Maccioni RB (2010) Neuroimmunomodulation in the pathogenesis of Alzheimer’s disease. Neuroimmunomodulation 17:202–204PubMedGoogle Scholar
  78. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS (2001) Sarcopenia. J Lab Clin Med 137:231–243PubMedGoogle Scholar
  79. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, Siadaty MS, Sanati S, Casscells W (2003) Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 107:762–768PubMedGoogle Scholar
  80. Nayak BN, Friel JK, Rempel CB, Jones PJ (2009) Energy-restricted diets result in higher numbers of CD4+, CD8+, immunoglobulins (A, M, and G), and CD45RA cells in spleen and CD4+, immunoglobulin A, and CD45RA cells in colonic lamina propria of rats. Nutr Res 29:487–493PubMedGoogle Scholar
  81. Parish ST, Wu JE, Effros RB (2009) Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. J Immunol 182:4237–4243PubMedPubMedCentralGoogle Scholar
  82. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A (2009) Cytomegalovirus and human immunosenescence. Rev Med Virol 19:47–56PubMedGoogle Scholar
  83. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8:157–168PubMedPubMedCentralGoogle Scholar
  84. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A (2011) Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J. 32: 1730–1735Google Scholar
  85. Qiu H, Straat K, Rahbar A, Wan M, Soderberg-Naucler C, Haeggstrom JZ (2008) Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells. J Exp Med 205:19–24PubMedPubMedCentralGoogle Scholar
  86. Reed JR, Vukmanovic-Stejic M, Fletcher JM, Soares MV, Cook JE, Orteu CH, Jackson SE, Birch KE, Foster GR, Salmon M, Beverley PC, Rustin MH, Akbar AN (2004) Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med 199:1433–1443PubMedPubMedCentralGoogle Scholar
  87. Rincon M, Pedraza-Alva G (2003) JNK and p38 MAP kinases in CD4+ and CD8+ T cells. Immunol Rev 192:131–142PubMedGoogle Scholar
  88. Riou C, Yassine-Diab B, Van Grevenynghe J, Somogyi R, Greller LD, Gagnon D, Gimmig S, Wilkinson P, Shi Y, Cameron MJ, Campos-Gonzalez R, Balderas RS, Kelvin D, Sekaly RP, Haddad EK (2007) Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med 204:79–91PubMedPubMedCentralGoogle Scholar
  89. Rossi JF, Negrier S, James ND, Kocak I, Hawkins R, Davis H, Prabhakar U, Qin X, Mulders P, Berns B (2010) A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer. Br J Cancer 103:1154–1162PubMedPubMedCentralGoogle Scholar
  90. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377:31–41PubMedGoogle Scholar
  91. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ (2011) Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 106:1340–1350PubMedPubMedCentralGoogle Scholar
  92. Schafer PH, Wang L, Wadsworth SA, Davis JE, Siekierka JJ (1999) T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes. J Immunol 162:659–668PubMedGoogle Scholar
  93. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M (2006) Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Ann N Y Acad Sci 1069:420–427PubMedGoogle Scholar
  94. Sethi JK, Vidal-Puig AJ (2007) Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48:1253–1262PubMedGoogle Scholar
  95. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6:e16103PubMedPubMedCentralGoogle Scholar
  96. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165:265–272PubMedGoogle Scholar
  97. Siscovick DS, Raghunathan TE, Lin D, Weinmann S, Arbogast P, Lemaitre RN, Psaty BM, Alexander R, Cobb LA (2000) Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 152:674–677PubMedGoogle Scholar
  98. Sobieszczyk, ME, Hoover, DR, Anastos, K, Mulligan, K, Tan, T, Shi, Q, Gao, W, Hyman, C, Cohen, MH, Cole, SR, Plankey, MW, Levine, AM, Justman, J (2008) Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 48:272–280Google Scholar
  99. Swindell, WR (2009) Genes and gene expression modules associated with caloric restriction and aging in the laboratory mouse. BMC Genomics. 10:585.Google Scholar
  100. Vainas T, Sayed S, Bruggeman CA, Stassen FR (2009) Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review. Drugs Today 45(Suppl B):165–172Google Scholar
  101. van de Berg PJ, van Stijn A, ten Berge IJ, van Lier RA (2008) A fingerprint left by cytomegalovirus infection in the human T cell compartment. J Clin Virol 41:213–217PubMedGoogle Scholar
  102. van de Berg PJ, Griffiths SJ, Yong SL, Macaulay R, Bemelman FJ, Jackson S, Henson SM, ten Berge IJ, Akbar AN, van Lier RA (2010) Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol 184:3417–3423PubMedGoogle Scholar
  103. Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46:862–873PubMedGoogle Scholar
  104. Wang CS, Wang ST, Lai CT, Lin LJ, Chou P (2007a) Impact of influenza vaccination on major cause-specific mortality. Vaccine 25:1196–1203PubMedGoogle Scholar
  105. Wang Y, Yin B, Liu S, Xue S (2007b) Cardioprotective effect by tumor necrosis factor-alpha and interleukin-6 through late preconditioning in unstable angina patients. Arch Med Res 38:80–85PubMedGoogle Scholar
  106. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL (2000) Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 31:803–805PubMedGoogle Scholar
  107. Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, Fischer KH, Neuman B, Wurzner R, Grubeck-Loebenstein B (2007) Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 68:86–90PubMedGoogle Scholar
  108. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408–415PubMedGoogle Scholar
  109. Westlake SL, Colebatch AN, Baird J, Curzen N, Kiely P, Quinn M, Choy E, Ostor AJ, Edwards CJ (2011) Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 50:518–531Google Scholar
  110. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445–453PubMedGoogle Scholar
  111. Williams JG, Jurkovich GJ, Hahnel GB, Maier RV (1992) Macrophage priming by interferon gamma: a selective process with potentially harmful effects. J Leukoc Biol 52:579–584PubMedGoogle Scholar
  112. Zhang X, Sun S, Hwang I, Tough DF, Sprent J (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8:591–599PubMedGoogle Scholar
  113. Zhang X, Fujii H, Kishimoto H, LeRoy E, Surh CD, Sprent J (2002) Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells. J Exp Med 195:283–293PubMedPubMedCentralGoogle Scholar

Copyright information

© American Aging Association 2012

Authors and Affiliations

  • Richard Macaulay
    • 1
  • Arne N. Akbar
    • 1
  • Sian M. Henson
    • 1
  1. 1.Division of Infection and Immunity, Rayne InstituteUniversity College LondonLondonUK

Personalised recommendations